Dachaigh › Aillse sa bhlaire › Ohio › Columbus
Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an Columbus, OH
Tha 19 sgrùdaidhean airson Aillse sa bhlaire a’ lorg phàirtichean aig làraichean ann agus timcheall air Columbus (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
A’ fastadhÌre 2
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- Doctors Hospital, Columbus
- agus 1 a bharrachd
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
A’ fastadhÌre 3
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- agus 8 a bharrachd
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
A’ fastadhÌre 2
- Ohio State University Comprehensive Cancer Center, Columbus
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
A’ fastadhÌre 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
A’ fastadhÌre 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- agus 11 a bharrachd
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A’ fastadhÌre 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
A’ fastadhÌre 1
- Ohio State University, Columbus
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A’ fastadhÌre 2
- Ohio State University, Columbus
- Central Ohio Urology Group (US Urology Partners), Gahanna · 7 mìle air falbh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
A’ fastadhÌre 1
- The Ohio State University (OSU), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
A’ fastadhÌre 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A’ fastadhÌre 1/2
- Central Ohio Urology Group, Gahanna · 7 mìle air falbh
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
A’ fastadhSgrùdadh amharc
- The Ohio State University, Columbus
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
A’ fastadhÌre 2/3
- The James Outpatient Care West Campus, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A’ fastadhÌre 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A’ fastadhÌre 2
- Ohio State University Hospital, Columbus
- Ohio State University, Columbus
- OSU Wexner Medical Center & James Cancer Hospital, Columbus
- agus 2 a bharrachd
Blue Light Cystoscopy With Cysview® Registry
A’ fastadhSgrùdadh amharc
- Ohio State University Wexner Medical Center, Columbus
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Columbus
Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile
- New York City, NY35 sgrùdaidhean
- Nashville, TN31 sgrùdaidhean
- Houston, TX31 sgrùdaidhean
- Dallas, TX27 sgrùdaidhean
- Washington, DC26 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Baltimore, MD24 sgrùdaidhean
- Los Angeles, CA24 sgrùdaidhean
- St. Louis, MO22 sgrùdaidhean
- Seattle, WA21 sgrùdaidhean
- Chicago, IL21 sgrùdaidhean
- Philadelphia, PA21 sgrùdaidhean
Sgrùdaidhean eile ann an Columbus
- Aillse Sgamhain Neo-chealla-beag57 sgrùdaidhean
- Aillse a' bhroilleach40 sgrùdaidhean
- Cancer Ovarian39 sgrùdaidhean
- Aillse (gach seòrsa)38 sgrùdaidhean
- Ailseachadh nan Sgamhan37 sgrùdaidhean
- Leukemia myeloid geur35 sgrùdaidhean
- Leukemia Lymphocytic Cronach28 sgrùdaidhean
- Ailse metastatach27 sgrùdaidhean
- Ailse Endometrial25 sgrùdaidhean
- Aillse Prostata24 sgrùdaidhean
- Myeloma iomaill24 sgrùdaidhean
- Aillse colorectal24 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.